Hepatitis B surface antigenaemia in Kenyans with chronic liver disease

dc.contributor.author	Pettigrew, NM
dc.contributor.author	Bagshawe, AF
dc.contributor.author	Cameron, HM
dc.contributor.author	Cameron, CH
dc.contributor.author	Dorman, JM
dc.contributor.author	MacSween, RNM
dc.date.accessioned	2015-10-01T08:53:56Z
dc.date.available	2015-10-01T08:53:56Z
dc.date.issued	1976
dc.identifier.citation	Transactions of the Royal Society of Tropical Medicine and Hygiene Volume 70, Issues 5–6, 1976, Pages 462-465	en_US
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/0035920376901309
dc.identifier.uri	http://hdl.handle.net/11295/91698
dc.description.abstract	Fifty Kenyan patients with chronic liver disease or hepatocellular carcinoma were tested for hepatitis B surface antigenaemia by radioimmunoassay. The hepatitis B surface antigen was detected in 77% of the patients with chronic persistent or chronic aggressive hepatitis, or cirrhosis confirmed by liver biopsy, compared with 15% in a control group. All six patients with hepatocellular carcinoma had detectable hepatitis B surface antigen or antibody. 50% of the controls had hepatitis B surface antibody in their plasma detectable by haemagglutination. Auto-immune associated liver disease appeared infrequent. The possibility that the hepatitis B virus is an important cause of cirrhosis in Kenya is discussed.	en_US
dc.language.iso	en	en_US
dc.publisher	University of Nairobi	en_US
dc.title	Hepatitis B surface antigenaemia in Kenyans with chronic liver disease	en_US
dc.type	Article	en_US
dc.type.material	en	en_US